By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech To Attend The 10th Kempen Life Sciences Conference 4/5/2017 11:28:23 AM
DBV Tech, BioNet-Asia And Geneva University Hospitals Announce Phase I Trial Results Of Viaskin rPT In Pertussis Booster Vaccination 3/31/2017 8:51:06 AM
DBV Tech Announces Filing Of Its 2016 "Document De Référence" And Annual Report On Form 20-F 3/23/2017 10:19:14 AM
DBV Tech Reports Full Year 2016 Financial Results 3/15/2017 9:42:35 AM
DBV Tech Announces Completion Of Enrollment Of The REALISE Study In Peanut Allergic Children 3/10/2017 7:32:48 AM
DBV Tech Release: Data At AAAAI 2017 Show Lasting Response And Favorable Safety Profile Of Investigational Agent, Viaskin Peanut, Throughout Three Years Of Treatment Of Peanut Allergic Children 3/6/2017 9:08:21 AM
DBV Tech To Attend Upcoming Investor Conferences 3/1/2017 9:17:47 AM
DBV Tech To Present Data At The 2017 AAAAI Meeting Highlighting The Therapeutic Potential Of EPIT 2/13/2017 1:47:15 PM
DBV Tech Announces Completion Of Enrollment Of Phase IIA Study Of Viaskin Milk For The Treatment Of Pediatric Eosinophilic Esophagitis 2/3/2017 11:39:13 AM
DBV Tech Announces Financial Calendar 2017 1/9/2017 9:57:17 AM